Sir Patrick has already sold more than £5 million in shares he received during his tenure as president of GlaxoSmithKline from 2012 to 2018.
Via: Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker GSK
Categories: English News